The Southern Gas Limited (BOM:509910)

Market Cap	535.73K
Revenue (ttm)	357.12M
Net Income (ttm)	18.12M
Shares Out	22.50K
EPS (ttm)	779.22
PE Ratio	0.03
Forward PE	n/a
Dividend	50.00 (100.00%)
Ex-Dividend Date	Sep 17, 2024

Volume	5
Average Volume	311
Open	23.81
Previous Close	n/a
Day's Range	23.81 - 23.81
52-Week Range	23.81 - 23.81
Beta	-0.14
RSI	n/a
Earnings Date	Aug 8, 2025

About Inozyme Pharma

The Southern Gas Limited manufactures and supplies industrial, medical, and rare gases in India. The company offers a range of gaseous products, such as oxygen, nitrogen, argon, hydrogen, nitrous oxide, acetylene, helium, and carbon dioxide, as well as gas mixtures. It serves automobile, cement, food, electrical, electronic, light, welding, fertilizer, aeronautical, power generation, gas, petrochemical, space research, metallurgical, emission testing, pollution control, and medical equipment industries, as well as atomic centers, nuclear statio...

• Industry: Industrial Gases
• Founded: 1963
• Employees: 107
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 509910

Financial Performance

In 2024, The Southern Gas's revenue was 357.12 million, an increase of 0.33% compared to the previous year's 355.96 million. Earnings were 18.12 million, an increase of 0.19%.